Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder

BJU International

Volumn 109, Issue 11, 2012, Pages 1716-1726

  Miyamoto, Hiroshi ^a   Yao, Jorge L ^a   Chaux, Alcides ^b   Zheng, Yichun ^a   Hsu, Iawen ^a   Izumi, Koji ^a   Chang, Chawnshang ^a   Messing, Edward M ^a   Netto, George J ^b   Yeh, Shuyuan ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

androgen receptor; bladder tumour; immunohistochemistry; oestrogen receptor; progression; recurrence

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; COHORT ANALYSIS; DISEASE ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MORTALITY; MUSCLE METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR CLASSIFICATION; TUMOR RECURRENCE; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84860600879     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10706.x     Document Type: Article

References (32)

1. Goebell PJ, Knowles MA,. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol Oncol 2010; 28: 409-28
2. Miyamoto H, Miller JS, Fajardo DA, Lee TK, Netto GJ, Epstein JI,. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system. Pathol Int 2010; 60: 1-8
3. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
4. Scosyrev E, Noyes K, Feng C, Messing E,. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009; 115: 68-74
5. Salmi S, Santti R, Gustafsson J-Å, Makela S,. Co-localization of androgen receptor with estrogen receptor β in the lower urinary tract of the male rat. J Urol 2001; 166: 674-7 (Pubitemid 32655035)
6. Celayir S, Ilçe Z, Dervisoglu S,. The sex hormone receptors in the bladder in childhood-I. Preliminary report in male subjects. Eur J Pediatr Surg 2002; 12: 312-7 (Pubitemid 35434697)
7. Chavalmane AK, Comeglio P, Morelli A, et al,. Sex steroid receptors in male human bladder: expression and biological function. J Sex Med 2010; 7: 2698-713
8. Waalkes MP, Liu J, Ward JM, Powell DA, Diwan BA,. Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res 2006; 66: 1337-45 (Pubitemid 43259912)
9. Miyamoto H, Yang Z, Chen Y-T, et al,. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007; 99: 558-68 (Pubitemid 47078733)
10. Sonpavde G, Okuno N, Weiss H, et al,. Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Urology 2007; 69: 1221-6 (Pubitemid 46891583)
11. Johnson AM, O'Connell MJ, Miyamoto H, et al,. Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospodin-1. BMC Urol 2008; 8: 7
12. Teng J, Wang Z-Y, Jarrard DF, Bjorling DE,. Roles of estrogen receptor α and β in modulating urothelial cell proliferation. Endocr Relat Cancer 2008; 15: 351-64 (Pubitemid 351449753)
13. Wu J-T, Han B-M, Yu S-Q, Wang H-P, Xia S-J,. Androgen receptor is a potential therapeutic target for bladder cancer. Urology 2009; 75: 820-7
14. Boorjian SA, Ugras S, Mongan NP, et al,. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 2004; 64: 383-8 (Pubitemid 39092488)
15. Croft PR, Lathrop SL, Feddersen RM, Joste NE,. Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma. Arch Pathol Lab Med 2005; 129: 194-9 (Pubitemid 40204797)
16. Shen SS, Smith CL, Hsieh J-T, et al,. Expression of estrogen receptor-α and -β in bladder cancer cell lines and human bladder tumor tissue. Cancer 2006; 106: 2610-6
17. Boorjian S, Heemers HV, Frank I, et al,. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. Endocr Relat Cancer 2009; 16: 123-37
18. Bolenz C, Lotan Y, Ashfaq R,. Estrogen and progesterone hormone receptor expression in urothelial carcinoma of the bladder. Eur Urol 2009; 56: 1093-5
19. Kontos S, Kominea A, Melachrinou M, Balampani E, Sotiropoulou-Bonikou G,. Inverse expression of estrogen receptor-β and nuclear factor-κB in urinary bladder carcinogenesis. Int J Urol 2010; 17: 801-10
20. Mir C, Shariat SF, van der Kwast TH, et al,. Loss of androgen receptor expression is not associated with pathological grade, stage, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int 2011; 108: 24-30
21. Tuygun C, Kankaya D, Imamoglu A, et al,. Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 2011; 29: 43-51
22. Zheng Y, Izumi K, Yao JL, Miyamoto H,. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells. Endocr Relat Cancer 2011; 18: 451-64
23. Schultz L, Albadine R, Hicks J, et al,. Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy. Cancer 2010; 116: 5517-26
24. Loar E, Schiffman ZJ, Braunstein JD, et al,. Androgen receptors in bladder tumors. Urology 1985; 25: 161-3 (Pubitemid 16078231)
25. Noronha RFX, Rao BR,. Sex hormone receptors in localized and advanced transitional cell carcinoma of urinary tract in humans. Urology 1986; 28: 401-3
26. Zhuang Y-H, Bläuer M, Tammela T, Tuohimaa P,. Immunodetection of androgen receptor in human urinary bladder cancer. Histopathology 1997; 30: 556-62 (Pubitemid 27254945)
27. Birtle AJ, Freeman A, Munson P,. The androgen receptor revisited in urothelial carcinoma. Histopathology 2004; 45: 98-9 (Pubitemid 38969574)
28. Kaufmann O, Baume H, Dietel M,. Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique. J Pathol 1998; 186: 165-8 (Pubitemid 28467826)
29. Basakci A, Kirkali Z, Tuzel E, Yorukoglu K, Mungan MU, Sade M,. Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder. Eur Urol 2002; 41: 342-5 (Pubitemid 35303436)
30. Reid LM, Leav I, Kwan PWL, Russell P, Merk FB,. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Cancer Res 1984; 44: 4560-73 (Pubitemid 14008779)
31. Kim HT, Kim BC, Kim IY, et al,. Raloxifen, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells. J Biol Chem 2002; 36: 32510-5 (Pubitemid 34984754)
32. Gown AM,. Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol 2008; 21: S8-15 (Pubitemid 351592775)